| 000 | 01542 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517112957.0 | ||
| 264 | 0 | _c20171208 | |
| 008 | 201712s 0 0 eng d | ||
| 022 | _a1873-3360 | ||
| 024 | 7 |
_a10.1016/j.psyneuen.2016.08.020 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAzevedo Da Silva, Marine | |
| 245 | 0 | 0 |
_aLongitudinal association of antidepressant medication use with metabolic syndrome: Results of a 9-year follow-up of the D.E.S.I.R. cohort study. _h[electronic resource] |
| 260 |
_bPsychoneuroendocrinology _c12 2016 |
||
| 300 |
_a34-45 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntidepressive Agents _xadverse effects |
| 650 | 0 | 4 |
_aAntidepressive Agents, Tricyclic _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aFrance _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLongitudinal Studies |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetabolic Syndrome _xchemically induced |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aSelective Serotonin Reuptake Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aSex Factors |
| 700 | 1 | _aBalkau, Beverley | |
| 700 | 1 | _aRoussel, Ronan | |
| 700 | 1 | _aTichet, Jean | |
| 700 | 1 | _aFumeron, Frédéric | |
| 700 | 1 | _aFagherazzi, Guy | |
| 700 | 1 | _aNabi, Hermann | |
| 773 | 0 |
_tPsychoneuroendocrinology _gvol. 74 _gp. 34-45 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.psyneuen.2016.08.020 _zAvailable from publisher's website |
| 999 |
_c26365738 _d26365738 |
||